182 related articles for article (PubMed ID: 1311061)
1. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
Mitsudomi T; Steinberg SM; Nau MM; Carbone D; D'Amico D; Bodner S; Oie HK; Linnoila RI; Mulshine JL; Minna JD
Oncogene; 1992 Jan; 7(1):171-80. PubMed ID: 1311061
[TBL] [Abstract][Full Text] [Related]
2. Imaging primary lung cancers in mice to study radiation biology.
Kirsch DG; Grimm J; Guimaraes AR; Wojtkiewicz GR; Perez BA; Santiago PM; Anthony NK; Forbes T; Doppke K; Weissleder R; Jacks T
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):973-7. PubMed ID: 20206017
[TBL] [Abstract][Full Text] [Related]
3. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website.
Bamford S; Dawson E; Forbes S; Clements J; Pettett R; Dogan A; Flanagan A; Teague J; Futreal PA; Stratton MR; Wooster R
Br J Cancer; 2004 Jul; 91(2):355-8. PubMed ID: 15188009
[TBL] [Abstract][Full Text] [Related]
4. p53: a frequent target for genetic abnormalities in lung cancer.
Takahashi T; Nau MM; Chiba I; Birrer MJ; Rosenberg RK; Vinocour M; Levitt M; Pass H; Gazdar AF; Minna JD
Science; 1989 Oct; 246(4929):491-4. PubMed ID: 2554494
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.
Bodner SM; Minna JD; Jensen SM; D'Amico D; Carbone D; Mitsudomi T; Fedorko J; Buchhagen DL; Nau MM; Gazdar AF
Oncogene; 1992 Apr; 7(4):743-9. PubMed ID: 1565469
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutations in nonsmall cell lung cancer.
Mogi A; Kuwano H
J Biomed Biotechnol; 2011; 2011():583929. PubMed ID: 21331359
[TBL] [Abstract][Full Text] [Related]
7. NCI-Navy Medical Oncology Branch cell line data base.
Phelps RM; Johnson BE; Ihde DC; Gazdar AF; Carbone DP; McClintock PR; Linnoila RI; Matthews MJ; Bunn PA; Carney D; Minna JD; Mulshine JL
J Cell Biochem Suppl; 1996; 24():32-91. PubMed ID: 8806092
[TBL] [Abstract][Full Text] [Related]
8. The uptake and efflux of doxorubicin by a sensitive human bladder cancer cell line and its doxorubicin-resistant subline.
Usansky JI; Liebert M; Wedemeyer G; Grossman HB; Wagner JG
Sel Cancer Ther; 1991; 7(4):139-50. PubMed ID: 1822001
[TBL] [Abstract][Full Text] [Related]
9. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF
Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma.
Iwakawa R; Kohno T; Enari M; Kiyono T; Yokota J
Cancer Sci; 2010 Aug; 101(8):1891-6. PubMed ID: 20557307
[TBL] [Abstract][Full Text] [Related]
11. Next-generation characterization of the Cancer Cell Line Encyclopedia.
Ghandi M; Huang FW; Jané-Valbuena J; Kryukov GV; Lo CC; McDonald ER; Barretina J; Gelfand ET; Bielski CM; Li H; Hu K; Andreev-Drakhlin AY; Kim J; Hess JM; Haas BJ; Aguet F; Weir BA; Rothberg MV; Paolella BR; Lawrence MS; Akbani R; Lu Y; Tiv HL; Gokhale PC; de Weck A; Mansour AA; Oh C; Shih J; Hadi K; Rosen Y; Bistline J; Venkatesan K; Reddy A; Sonkin D; Liu M; Lehar J; Korn JM; Porter DA; Jones MD; Golji J; Caponigro G; Taylor JE; Dunning CM; Creech AL; Warren AC; McFarland JM; Zamanighomi M; Kauffmann A; Stransky N; Imielinski M; Maruvka YE; Cherniack AD; Tsherniak A; Vazquez F; Jaffe JD; Lane AA; Weinstock DM; Johannessen CM; Morrissey MP; Stegmeier F; Schlegel R; Hahn WC; Getz G; Mills GB; Boehm JS; Golub TR; Garraway LA; Sellers WR
Nature; 2019 May; 569(7757):503-508. PubMed ID: 31068700
[TBL] [Abstract][Full Text] [Related]
12. The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53.
Göttig L; Jummer S; Staehler L; Groitl P; Karimi M; Blanchette P; Kosulin K; Branton PE; Schreiner S
J Virol; 2024 Apr; 98(4):e0170123. PubMed ID: 38451084
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin Induces Spermidine/Spermine-N
Buelvas N; Ugarte-Vio I; Asencio-Leal L; Muñoz-Uribe M; Martin-Martin A; Rojas-Fernández A; Jara JA; Tapia JC; Arias ME; López-Muñoz RA
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759783
[TBL] [Abstract][Full Text] [Related]
14. A study on metabolic characteristics and metabolic markers of gastrointestinal tumors.
Cong S; Bai S; Zhang M; Bi Y; Wang Y; Jin S; He H
Cancer Biol Ther; 2023 Dec; 24(1):2255369. PubMed ID: 37705174
[TBL] [Abstract][Full Text] [Related]
15. Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling.
Walter DM; Gladstein AC; Doerig KR; Natesan R; Baskaran SG; Gudiel AA; Adler KM; Acosta JO; Wallace DC; Asangani IA; Feldser DM
Commun Biol; 2023 Mar; 6(1):255. PubMed ID: 36899051
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Health, Mitochondrial Fitness, Physical Activity, and Cancer.
Clemente-Suárez VJ; Martín-Rodríguez A; Redondo-Flórez L; Ruisoto P; Navarro-Jiménez E; Ramos-Campo DJ; Tornero-Aguilera JF
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765772
[TBL] [Abstract][Full Text] [Related]
17. Mutation and up-regulation of TP53 in ovine pulmonary adenocarcinoma lung cells as a model of human lung cancer.
Shadmehri M; Ashrafi-Helan J; Firouzamandi M
Vet Res Forum; 2022 Sep; 13(3):349-356. PubMed ID: 36320308
[TBL] [Abstract][Full Text] [Related]
18. Ordered micropattern arrays fabricated by lung-derived dECM hydrogels for chemotherapeutic drug screening.
Zhu X; Li Y; Yang Y; He Y; Gao M; Peng W; Wu Q; Zhang G; Zhou Y; Chen F; Bao J; Li W
Mater Today Bio; 2022 Jun; 15():100274. PubMed ID: 35601895
[TBL] [Abstract][Full Text] [Related]
19. The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA.
Weller S; Toennießen A; Schaefer B; Beigl T; Muenchow A; Böpple K; Hofmann U; Gillissen BF; Aulitzky WE; Kopp HG; Essmann F
Cell Death Discov; 2022 Apr; 8(1):215. PubMed ID: 35443750
[TBL] [Abstract][Full Text] [Related]
20. A Single Amino Acid Switch in the Adenoviral DNA Binding Protein Abrogates Replication Center Formation and Productive Viral Infection.
Boddin J; Ip WH; Wilkens B; von Stromberg K; Ching W; Koyuncu E; Bertzbach LD; Dobner T
mBio; 2022 Apr; 13(2):e0014422. PubMed ID: 35254132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
